Grace Therapeutics, Inc.
GRCE
$4.44
-$0.01-0.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.98M | -7.82M | -10.31M | -9.57M | -13.37M |
| Total Depreciation and Amortization | 7.00K | 6.00K | 8.00K | 7.00K | 6.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.81M | -3.23M | -3.02M | -5.69M | -1.79M |
| Change in Net Operating Assets | -346.00K | -974.00K | 211.00K | 342.00K | 1.11M |
| Cash from Operations | -10.13M | -12.01M | -13.11M | -14.90M | -14.04M |
| Capital Expenditure | -- | -- | -- | -- | -22.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 1.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 15.00K | 15.00K | 0.00 | 6.57M |
| Cash from Investing | 0.00 | 15.00K | 15.00K | 0.00 | 6.55M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.04M | 15.00M | 15.00M | 15.00M | 162.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.29M | -1.29M | -1.29M | -967.00K | -162.00K |
| Cash from Financing | 17.75M | 13.71M | 13.71M | 14.03M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.62M | 1.71M | 611.00K | -872.00K | -7.49M |